PressFebruary 20, 2024 Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds
PressFebruary 15, 2024 MindBio Therapeutics Completes World First Take Home Phase 2a Microdosing Depression Trial
PressFebruary 9, 2024 PharmAla and Red Light Holland to Collaborate on Medical Psilocybin Development
PressFebruary 9, 2024 Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
PressFebruary 7, 2024 Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program
PressFebruary 6, 2024 Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with BIRAD
PressFebruary 6, 2024 Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China
PressFebruary 2, 2024 Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology
PressFebruary 2, 2024 Numinus Wellness Inc. Announces $6 Million Bought Deal Public Offering with Leads Orders from MAPS and Integrated V.C.
PressFebruary 2, 2024 Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center
PressFebruary 2, 2024 Revive Therapeutics Ltd. Announces Closing of the First Tranche of Its Private Placement for Gross Proceeds of $913,500
PressFebruary 2, 2024 PharmAla releases Profitable Q1 Interim Financial Statement and Business Update
PressJanuary 31, 2024 Algernon Pharmaceuticals Receives Notice of Intention to Grant from Chinese Patent Office for Repirinast to Treat CKD
PressJanuary 31, 2024 Magdalena Biosciences, a Joint Venture between Jaguar Health and Filament Health, Study Indicates Psychoactive Activity of Medicinal Plant Utilized for Centuries by Indigenous Peoples in Tropical Regions
PressJanuary 31, 2024 Filament Health Announces FDA Opening of Investigational New Drug Application for Substance Use Disorders
PressJanuary 31, 2024 PharmAla releases Profitable Q1 Interim Financial Statement and Business Update
